Company Filing History:
Years Active: 2020-2023
Title: Steven Michael Erb: Innovator in Flavivirus Stabilization
Introduction
Steven Michael Erb is a notable inventor based in Fort Collins, Colorado. He has made significant contributions to the field of virology, particularly in the stabilization of flaviviruses. With a total of 2 patents, his work has implications for vaccine development and storage.
Latest Patents
Erb's latest patents focus on "Compositions and methods for stabilizing flaviviruses with improved formulations." These patents detail various embodiments that relate to stabilizing live, attenuated, or unattenuated flaviviruses. The inventions aim to reduce degradation during manufacturing, storage, and transport. Additionally, they include improved formulations that prolong the stabilization of these viruses, which is crucial for their effectiveness in medical applications.
Career Highlights
Steven Michael Erb is currently associated with Takeda Vaccines, Inc., where he continues to innovate in the field of vaccine technology. His expertise in stabilizing flaviviruses has positioned him as a key player in the development of effective vaccines.
Collaborations
Throughout his career, Erb has collaborated with notable colleagues, including Jill Ann Livengood and Linda Marie Strange. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Steven Michael Erb's work in stabilizing flaviviruses represents a significant advancement in vaccine technology. His contributions are vital for improving the efficacy and transportability of vaccines, ultimately benefiting public health.